Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Pfizer Inc. PFE
$37.29
-$0.29 (-0.79%)
На 18:00, 12 мая 2023
+62.08%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
210423236772.00000000
-
week52high
54.93
-
week52low
37.21
-
Revenue
100330000000
-
P/E TTM
7
-
Beta
0.58754300
-
EPS
5.38000000
-
Last Dividend
1.64000000
-
Next Earnings Date
26 июл 2023 г. в 12:30
Описание компании
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Barclays | Equal-Weight | Equal-Weight | 01 авг 2022 г. |
| SVB Leerink | Market Perform | Market Perform | 29 июл 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 08 июл 2022 г. |
| Wells Fargo | Overweight | Overweight | 04 мая 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 04 мая 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 12 окт 2022 г. |
| Barclays | Equal-Weight | Equal-Weight | 12 окт 2022 г. |
| SVB Leerink | Market Perform | Market Perform | 11 окт 2022 г. |
| SVB Leerink | Market Perform | Market Perform | 03 ноя 2022 г. |
| Wells Fargo | Overweight | Overweight | 02 ноя 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 02 ноя 2022 г. |
| Barclays | Equal-Weight | Equal-Weight | 02 ноя 2022 г. |
| Credit Suisse | Outperform | 18 ноя 2022 г. | |
| B of A Securities | Neutral | Buy | 04 янв 2023 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 14 дек 2022 г. |
| Goldman Sachs | Buy | Neutral | 13 дек 2022 г. |
| Wells Fargo | Equal-Weight | Overweight | 17 янв 2023 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 01 февр 2023 г. |
| Credit Suisse | Outperform | Outperform | 01 февр 2023 г. |
| Cantor Fitzgerald | Overweight | 01 февр 2023 г. | |
| BMO Capital | Outperform | Outperform | 01 февр 2023 г. |
| UBS | Neutral | Buy | 26 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| BOURLA ALBERT | A | 96522 | 41 | 12 янв 2023 г. |
| DAMICO JENNIFER B. | A | 19021 | 121 | 12 янв 2023 г. |
| JOHNSON RADY A | A | 7423 | 16 | 12 янв 2023 г. |
| Echevarria Joseph | A | 86802 | 903 | 30 дек 2022 г. |
| NARAYEN SHANTANU | A | 113786 | 976 | 30 дек 2022 г. |
| Quincey James | A | 27027 | 756 | 30 дек 2022 г. |
| SMITH JAMES C | A | 101393 | 878 | 30 дек 2022 г. |
| BOURLA ALBERT | A | 96430 | 10 | 30 дек 2022 г. |
| DAMICO JENNIFER B. | A | 18889 | 25 | 30 дек 2022 г. |
| JOHNSON RADY A | A | 7403 | 3 | 30 дек 2022 г. |
Institutional Ownership
Institutional Ownership
| Holder | Shares | Change | Date Reported |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 156549000 | -1357890 | 31 авг 2020 г. |
| Vanguard 500 Index Fund | 114141000 | -407205 | 31 авг 2020 г. |
| SPDR S&P 500 ETF | 58587100 | -277801 | 31 авг 2020 г. |
| US Bank Vanguard Institutional 500 Index Trust | 47725600 | -219677 | 31 авг 2020 г. |
| Fidelity 500 Index Fund | 49479500 | -53545 | 31 июл 2020 г. |
| American Funds Washington Mutual Investors Fund | 75963500 | 9632200 | 30 июн 2020 г. |
| Vanguard Health Care Fund | 72260200 | 8145620 | 30 июн 2020 г. |
| American Funds American Balanced Fund | 56248000 | 2319000 | 30 июн 2020 г. |
| Vanguard Wellington Fund | 53432100 | 9397740 | 30 июн 2020 г. |
| American Funds Income Fund of America | 53210000 | 4010000 | 30 июн 2020 г. |
Новостная лента
Pfizer CEO says Medicare will likely face legal action over drug price negotiations
CNBC
11 мая 2023 г. в 17:23
Pfizer CEO Albert Bourla argued the Biden administration's plan will cut profits and force Big Pharma companies to pull back on developing medicines.
The FDA Just Approved an RSV Vaccine -- and It Isn't From Moderna or Pfizer
The Motley Fool
11 мая 2023 г. в 10:23
The global RSV vaccine market isn't all that big, and healthcare giants are battling for market share. Potential vaccines from Pfizer and Moderna have demonstrated high efficacy in late-stage trials.
As COVID public health emergency ends, ‘whack-a-mole' virus won't be easy to track
Market Watch
10 мая 2023 г. в 14:30
As the U.S. COVID-19 public health emergency comes to an end on Thursday, the fight against COVID goes on–-and some new challenges begin for those who hope to keep the virus at bay.
U.S. Wide-Moat Stocks On Sale - The May 2023 Heat Map
Seeking Alpha
10 мая 2023 г. в 00:39
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison.
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Zacks Investment Research
08 мая 2023 г. в 10:40
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.